ACCESSION: MSBNK-SMB_Measured-HSA001P0111028
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 76
COMMENT: RAW_SPEC {'BLK02_313': {'bp': 760841.0, 'sum': 1893363.0}, '11_posi_418': {'bp': 662941.0, 'sum': 1515404.0}, '16_posi_207': {'bp': 669586.0, 'sum': 1651983.0}, 'ProcedureBlank_375': {'bp': 678314.0, 'sum': 1674198.0}, '14_posi_82': {'bp': 690944.0, 'sum': 1772242.0}, '4_posi_209': {'bp': 699989.0, 'sum': 1692506.0}, 'BLK02_123': {'bp': 714263.0, 'sum': 1825690.0}, '7_posi_271': {'bp': 722736.0, 'sum': 1681598.0}, '6_posi_102': {'bp': 730330.0, 'sum': 1846720.0}, '11_posi_249': {'bp': 641137.0, 'sum': 1585298.0}, '12_posi_165': {'bp': 653079.0, 'sum': 1673650.0}, '15_posi_334': {'bp': 654878.0, 'sum': 1566707.0}, '6_posi_356': {'bp': 713881.0, 'sum': 1677850.0}, '12_posi_77': {'bp': 734445.0, 'sum': 1837301.0}, '2_posi_188': {'bp': 735405.0, 'sum': 1791182.0}, '19_posi_166': {'bp': 579982.0, 'sum': 1519724.0}, '18_posi_187': {'bp': 636776.0, 'sum': 1669352.0}, '16_posi_398': {'bp': 686896.0, 'sum': 1625533.0}, '1_posi_83': {'bp': 689070.0, 'sum': 1773760.0}, '10_posi_230': {'bp': 697168.0, 'sum': 1697821.0}, '13_posi_188': {'bp': 700809.0, 'sum': 1657630.0}, '7_posi_104': {'bp': 733936.0, 'sum': 1780939.0}, '3_posi_397': {'bp': 739763.0, 'sum': 1773448.0}, '18_posi_292': {'bp': 624699.0, 'sum': 1573347.0}, '15_posi_207': {'bp': 671810.0, 'sum': 1647760.0}, '13_posi_102': {'bp': 702666.0, 'sum': 1707953.0}, '8_posi_104': {'bp': 716413.0, 'sum': 1806639.0}, '10_posi_83': {'bp': 729000.0, 'sum': 1819462.0}, '19_posi_352': {'bp': 652448.0, 'sum': 1567793.0}, '17_posi_79': {'bp': 663938.0, 'sum': 1672147.0}, '14_posi_248': {'bp': 667551.0, 'sum': 1622670.0}, '6_posi_187': {'bp': 667657.0, 'sum': 1673691.0}, '9_posi_81': {'bp': 678968.0, 'sum': 1724076.0}, '7_posi_187': {'bp': 687513.0, 'sum': 1628118.0}, '2_posi_81': {'bp': 751098.0, 'sum': 1880429.0}, '19_posi_79': {'bp': 555886.0, 'sum': 1594152.0}, '14_posi_165': {'bp': 672756.0, 'sum': 1693663.0}, '14_posi_334': {'bp': 686091.0, 'sum': 1626676.0}, '3_posi_188': {'bp': 712668.0, 'sum': 1718759.0}, '8_posi_206': {'bp': 719146.0, 'sum': 1749360.0}, '9_posi_271': {'bp': 652281.0, 'sum': 1616070.0}, '15_posi_124': {'bp': 660861.0, 'sum': 1720495.0}, '9_posi_186': {'bp': 663318.0, 'sum': 1693235.0}, '8_posi_314': {'bp': 688187.0, 'sum': 1677761.0}, '12_posi_251': {'bp': 688592.0, 'sum': 1706851.0}, '12_posi_354': {'bp': 718988.0, 'sum': 1687100.0}, '7_posi_376': {'bp': 734575.0, 'sum': 1726411.0}, '9_posi_376': {'bp': 712577.0, 'sum': 1676701.0}, '2_posi_293': {'bp': 722886.0, 'sum': 1767929.0}, '4_posi_121': {'bp': 715148.0, 'sum': 1805840.0}, 'ProcedureBlank_103': {'bp': 713896.0, 'sum': 1785299.0}, '4_posi_332': {'bp': 690144.0, 'sum': 1614929.0}, '13_posi_396': {'bp': 689521.0, 'sum': 1683499.0}, '5_posi_81': {'bp': 686188.0, 'sum': 1698760.0}, '17_posi_184': {'bp': 684028.0, 'sum': 1694962.0}, 'ProcedureBlank_272': {'bp': 682702.0, 'sum': 1682464.0}, '11_posi_83': {'bp': 676975.0, 'sum': 1708455.0}, '16_posi_80': {'bp': 666083.0, 'sum': 1684081.0}, '10_posi_335': {'bp': 642299.0, 'sum': 1576008.0}, '19_posi_245': {'bp': 547629.0, 'sum': 1449297.0}, '13_posi_293': {'bp': 724987.0, 'sum': 1688769.0}, '17_posi_352': {'bp': 671228.0, 'sum': 1658828.0}, '18_posi_104': {'bp': 659066.0, 'sum': 1708896.0}, '17_posi_268': {'bp': 629043.0, 'sum': 1623538.0}, '3_posi_314': {'bp': 735135.0, 'sum': 1780239.0}, '1_posi_226': {'bp': 729766.0, 'sum': 1792432.0}, 'BLK02_230': {'bp': 725911.0, 'sum': 1831103.0}, 'ProcedureBlank_187': {'bp': 687571.0, 'sum': 1730003.0}, '5_posi_185': {'bp': 668112.0, 'sum': 1651523.0}, '11_posi_333': {'bp': 652015.0, 'sum': 1558316.0}, '18_posi_375': {'bp': 608121.0, 'sum': 1512533.0}, '19_posi_440': {'bp': 542158.0, 'sum': 1364479.0}, '5_posi_288': {'bp': 650717.0, 'sum': 1568293.0}, '6_posi_272': {'bp': 675263.0, 'sum': 1657864.0}, '16_posi_311': {'bp': 692401.0, 'sum': 1709419.0}, '1_posi_314': {'bp': 679738.0, 'sum': 1704426.0}}
COMMENT: RETENTION_TIME_STDEV 0.211
COMMENT: PRECURSOR_M/Z_RAW 111.091736
COMMENT: PRECURSOR_M/Z_STDEV 0.000031
COMMENT: PRECURSOR_IN_MS1 mz 111.091684; int 119.169; delta(ppm) 1.474938
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 128.118209; int 734.467; cor 0.784
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.055; C6H10N2; [M+H]+; delta(ppm) 0.054504
COMMENT: PROPOSED_MF MS-FINDER 2.809; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.949; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.867; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.694; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.587; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.587; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.587; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.486; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.486; VTNUQSAAFBRENH-UHFFFAOYSA-N; [M+H]+; 1,2-dimethyl-1??-pyrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.444; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.961; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.848; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.847; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.820; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.740; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.986; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.664; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.721; MKBBSFGKFMQPPC-UHFFFAOYSA-N; [M+H]+; 2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.610; FUOZJYASZOSONT-UHFFFAOYSA-N; [M+H]+; 2-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.603; YAVXLTMRALFZIS-UHFFFAOYSA-N; [M+H]+; piperidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.562; KMBJEVSXNIUPIH-UHFFFAOYSA-N; [M+H]+; 3-(aziridin-1-yl)butanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.502; NPRYXVXVLCYBNS-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.397; IPIORGCOGQZEHO-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.368; VDSAXHBDVIUOGV-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.313; YAXKXMVDJJMGRY-UHFFFAOYSA-N; [M+H]+; 4-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.311; VGFGZZVMDIZSTI-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclopropylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.306; IYVYLVCVXXCYRI-UHFFFAOYSA-N; [M+H]+; 1-propylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.302; HERJCJRIDHRCKG-UHFFFAOYSA-N; [M+H]+; 2-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.284; FSDNTQSJGHSJBG-UHFFFAOYSA-N; [M+H]+; piperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.282; UEBWHAAQVVWZAU-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.278; SFEKRFLQOGMHSZ-UHFFFAOYSA-N; [M+H]+; 2-[1-(aminomethyl)cyclopropyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.274; ZGNXATVKGIJQGC-UHFFFAOYSA-N; [M+H]+; piperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.272; KFPMRYNOEZCHDP-UHFFFAOYSA-N; [M+H]+; 1-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.261; FVPYQTSLDMVWBM-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.259; NYYVCPHBKQYINK-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.258; PKTNSCWXNMMDQK-UHFFFAOYSA-N; [M+H]+; 3-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.253; ZKKCALAGXBADEJ-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-3-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; NALRGBZDHLOOTD-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.246; BDMFEFZOOOYCKN-UHFFFAOYSA-N; [M+H]+; 1-propylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.244; LZECJKUQMLXNBD-UHFFFAOYSA-N; [M+H]+; 1-amino-2,2-dimethylcyclopropane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.224; ZAXITHHHFYZUGN-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.179; ZICRALLMHKILDG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.164; KYCDNQPIQHCAFW-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.162; RFBQAWJJJXBCSN-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.159; HUVAAOZUPLEYBH-UHFFFAOYSA-N; [M+H]+; 3,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.146; JTAPOORUPPEREW-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.146; WVMBISZHWMJNNM-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; GGCBARJYVAPZJQ-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; ZAOLDHBNVDOBDU-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; OZHWHTICSNFGBZ-UHFFFAOYSA-N; [M+H]+; 3-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.131; NVPICXQHSYQKGM-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.129; UMMIQMAIGBATCS-UHFFFAOYSA-N; [M+H]+; 2-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; HINMGNHBDCADKG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; PTBPTNCGZUOCBK-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.091; HNOQAFMOBRWDKQ-UHFFFAOYSA-N; [M+H]+; 1,3,5-trimethylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; ANMVTDVBEDVFRB-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; HPDIRFBJYSOVKW-UHFFFAOYSA-N; [M+H]+; 2-pyrrol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.062; IAZZNTYMXXEHHT-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; ZBJSHMBQYSDTGK-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; ZOORJGVSPXCZCJ-UHFFFAOYSA-N; [M+H]+; N,N-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; YBTQATWVNNDUDN-UHFFFAOYSA-N; [M+H]+; 2-(3-aminocyclobutyl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; MRGFCRUGPMFUHD-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -79.859; MBAJKEJMOVVLRP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.356; NPRYXVXVLCYBNS; [M+H]+; Pyrrolidinoacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.527; OZHWHTICSNFGBZ; [M+H]+; ACMC-20ankz
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.857; JOHCCHGNXMXHPU; [M+H]+; 2,3-Diazabicyclo(2.2.2)oct-2-ene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -129.576; APYDCJBHJXFOTJ; [M+H]+; 2,3-Dihydro-5,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.248; ZGNXATVKGIJQGC; [M+H]+; 3-cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.058; VDSAXHBDVIUOGV; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.607; FSDNTQSJGHSJBG; [M+H]+; ACMC-20aipl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.873; NYYVCPHBKQYINK; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.945; NVPICXQHSYQKGM; [M+H]+; 1-Cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.884; NJMWOUFKYKNWDW; [M+H]+; Meetimcl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.022; IYVYLVCVXXCYRI; [M+H]+; propylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.879; HPDIRFBJYSOVKW; [M+H]+; pyrrolylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.366; IPIORGCOGQZEHO; [M+H]+; 1-Isopropylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.013; WLWHLUQQCLCFNE; [M+H]+; 1-ethenyl-3-methyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.416; KMBJEVSXNIUPIH; [M+H]+; 3-(1-Aziridinyl)butyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.024; PKTNSCWXNMMDQK; [M+H]+; 3-Aminocyclopentanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.484; KFPMRYNOEZCHDP; [M+H]+; Ambcb4035549
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.486; NJIDBKRVRJXCLL; [M+H]+; 1-methyl-2H-pyridin-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.425; FUOZJYASZOSONT; [M+H]+; 2-Isopropylimdazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.702; BDMFEFZOOOYCKN; [M+H]+; propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.101; ANMVTDVBEDVFRB; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.311; MKBBSFGKFMQPPC; [M+H]+; zlchem 316
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -255.349; GGCBARJYVAPZJQ; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.238; QBNRQCHCKIIYGV; [M+H]+; 3-Propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.521; ZICRALLMHKILDG; [M+H]+; zlchem 589
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.791; ULKLGIFJWFIQFF; [M+H]+; Imidazole C-2 deriv. 2
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.442; ZOORJGVSPXCZCJ; [M+H]+; 1-(Dimethylamino)pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.093; HINMGNHBDCADKG; [M+H]+; 5-propan-2-yl-1H-imidazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.534; HNOQAFMOBRWDKQ; [M+H]+; Pyrazole, 1,3,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.822; HUVAAOZUPLEYBH; [M+H]+; 3,4,5-Trimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -364.450; PTBPTNCGZUOCBK; [M+H]+; 2,4,5-Trimethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.389; MBAJKEJMOVVLRP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -48.933; MBAJKEJMOVVLRP; [M+H]+; 2,5-Dihydro-3,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -87.164; WLWHLUQQCLCFNE; [M+H]+; 1-Ethenyl-3-methyl-1,2-dihydroimidazol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -97.409; APYDCJBHJXFOTJ; [M+H]+; 2,3-Dihydro-5,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -106.443; MKBBSFGKFMQPPC; [M+H]+; 2-propyl-1H-imidazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -106.726; FUOZJYASZOSONT; [M+H]+; 2-Isopropylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.472; NPRYXVXVLCYBNS; [M+H]+; 1-Pyrrolidineacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.735; NYYVCPHBKQYINK; [M+H]+; 1-Ethyl-2-methyl-3H-imidazole-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.093; OZHWHTICSNFGBZ; [M+H]+; 3-(Cyclopropylamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.736; KMBJEVSXNIUPIH; [M+H]+; (3S)-3-(aziridin-1-yl)butanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.021; NJMWOUFKYKNWDW; [M+H]+; 1-Ethyl-3-methylimidazolium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.324; MBAJKEJMOVVLRP; [M+H]+; 2,5-Dihydro-3,6-dimethylpyrazine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H11N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.467
MS$FOCUSED_ION: PRECURSOR_M/Z 111.091680
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-3900000000-8b8ad873a61f2e8f3dd1
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495683 21.2185 56.050200 1.0883 2.91 0.2390 76 f{C3H6N1}/1.65ppm,p-C3H5N1
  68.0494990 113.6356 68.050130 0.2939 10.07 0.7220 76 f{C4H6N1}/0.34ppm,p-C2H5N1
  69.0446844 17.4275 69.045310 1.0138 3.15 0.3158 76 f{C3H5N2}/-0.58ppm,p-C3H6
  69.0698996 37.0594 69.070525 0.5646 5.70 0.1765 76 f{C5H9}/0.33ppm,p-C1H2N2
  70.0651405 38.5932 70.065760 0.6280 4.12 0.2895 76 f{C4H8N1}/0.21ppm,p-C2H3N1
  81.0446586 14.8129 81.045185 0.9501 2.93 0.2073 76 f{C4H5N2}/-0.81ppm,p-C2H6
  82.0525647 77.3412 82.053080 0.4387 7.74 0.3836 76 f{C4H6N2}/0.18ppm,p-C2H5
  82.0650749 17.2785 82.065590 1.2185 2.80 0.5032 76 f{C5H8N1}/-0.62ppm,p-C1H3N1
  83.0603863 331.7298 83.060890 0.2769 26.45 0.4286 76 f{C4H7N2}/0.14ppm,p-C2H4
  84.0443680 7.1027 84.044860 1.6896 1.79 0.0167 67 ?
  94.0400029 17.0998 94.040370 1.0953 3.08 0.0489 76 ?
  94.0651331 36.3616 94.065500 0.8611 4.30 0.5527 76 f{C6H8N1}/0.08ppm,p-H3N1
  96.0682125 11.6069 96.068565 1.4885 2.37 0.0813 76 f{C5H8N2}/0.13ppm,p-C1H3
  111.0553341 646.2856 111.055550 0.3062 58.08 0.3650 76 ?
  111.0754343 31.8204 111.075650 2.6198 3.44 0.3806 73 ?
  111.0916644 999.0000 111.091880 0.2520 11.73 1.0000 76 f{C6H11N2}/-0.09ppm,p
PK$NUM_PEAK: 16
PK$PEAK: m/z int. rel.int.
  56.049568 21.22 21
  68.049499 113.64 113
  69.044684 17.43 17
  69.069900 37.06 37
  70.065140 38.59 38
  81.044659 14.81 14
  82.052565 77.34 77
  82.065075 17.28 17
  83.060386 331.73 331
  84.044368 7.10 7
  94.040003 17.10 17
  94.065133 36.36 36
  96.068212 11.61 11
  111.055334 646.29 646
  111.075434 31.82 31
  111.091664 999.00 999
//
